Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
Mayo Clinic
National Institutes of Health Clinical Center (CC)
Blueprint Medicines Corporation
Reveal Pharmaceuticals Inc.
Seattle Children's Hospital
Massachusetts General Hospital
Arbor Pharmaceuticals, Inc.
Varian, a Siemens Healthineers Company
Mayo Clinic
National Institutes of Health Clinical Center (CC)
Cedars-Sinai Medical Center
Thomas Jefferson University
Thomas Jefferson University
Children's Oncology Group
Dana-Farber Cancer Institute